InnoCan Pharma Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 6.77 million compared to USD 1.56 million a year ago. Net loss was USD 1.77 million compared to USD 1.27 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 CAD | 0.00% | -3.85% | -19.35% |
1st Jan change | Capi. | |
---|---|---|
-19.35% | 5.12Cr | |
+55.05% | 81TCr | |
+43.62% | 64TCr | |
-6.86% | 35TCr | |
+18.04% | 33TCr | |
+8.44% | 30TCr | |
+16.30% | 25TCr | |
+2.41% | 22TCr | |
+12.47% | 22TCr | |
+9.09% | 17TCr |
- Stock Market
- Equities
- INNO Stock
- News InnoCan Pharma Corporation
- InnoCan Pharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024